Article
Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Gastroenterology - 1 Jun 2017
Weismüller Tobias J, Trivedi Palak J, Bergquist Annika, Imam Mohamad, Lenzen Henrike, Ponsioen Cyriel Y, Holm Kristian, Gotthardt Daniel, Färkkilä Martti A, Marschall Hanns-Ulrich, Thorburn Douglas, Weersma Rinse K, Fevery Johan, Mueller Tobias, Chazouillères Olivier, Schulze Kornelius, Lazaridis Konstantinos N, Almer Sven, Pereira Stephen P, Levy Cynthia, Mason Andrew, Naess Sigrid, Bowlus Christopher L, Floreani Annarosa, Halilbasic Emina, Yimam Kidist K, Milkiewicz Piotr, Beuers Ulrich, Huynh Dep K, Pares Albert, Manser Christine N, Dalekos George N, Eksteen Bertus, Invernizzi Pietro, Berg Christoph P, Kirchner Gabi I, Sarrazin Christoph, Zimmer Vincent, Fabris Luca, Braun Felix, Marzioni Marco, Juran Brian D, Said Karouk, Rupp Christian, Jokelainen Kalle, Benito de Valle Maria, Saffioti Francesca, Cheung Angela, Trauner Michael, Schramm Christoph, Chapman Roger W, Karlsen Tom H, Schrumpf Erik, Strassburg Christian P, Manns Michael P, Lindor Keith D, Hirschfield Gideon M, Hansen Bettina E, Boberg Kirsten M
Abstract excerpt
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical phenotypes in a large international cohort of patients with PSC. METHODS: We performed a retrospective outcome analysis of patients diagnosed with PSC from 1980 through 2010 at 37 centers in...
Read the complete abstract on PubMed